Publications by authors named "M R Posner"

Claim this Profile
M
Misclassification of p16-positive, HPV-negative patients biases de-escalation trials.
Jessica T Lovett, Michael T Wotman, Marshall Posner

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building attention on a firm foundation.
Michael I Posner

Behav Brain Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcomes of radiation-associated second primary malignancies in HPV-positive oropharyngeal cancer: long-term follow-up of the quarterback de-escalation trials.
J T Lovett, W H Westra, S Roof, R L Bakst, K Sindhu, M Posner

Oral Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A para-Bombay phenotype due to compound heterozygosity involving a novel FUT1 variant.
Melina Luján Brajovich, Cecilia González, Cintia Principi, Pamela Cribb, Marta Salgado, María Victoria Posner

Vox Sang· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.
Caroline Even, Kevin J Harrington, Erminia Massarelli, Simon Laban, Jérôme Fayette, Marshall Posner

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis